A heavily criticized recommendation from the Centers for Disease Control and Prevention last month about who should be tested for the coronavirus was not written by C.D.C. scientists and was posted to the agency’s website despite their serious objections, according to several people familiar with the matter as well as internal documents obtained by The… Read More »
The vaccine — developed through a collaboration between BIDMC and Johnson & Johnson (J&J) — uses a common cold virus, called adenovirus serotype 26 (Ad26), to deliver the SARS-CoV-2 spike protein into host cells, where it stimulates the body to raise immune responses against the coronavirus. Barouch’s group and J&J developed a series of vaccine… Read More »
Trial Population Table 1. Table 1. Characteristics of the Participants in the mRNA-1273 Trial at Enrollment. The 45 enrolled participants received their first vaccination between March 16 and April 14, 2020 (Fig. S1). Three participants did not receive the second vaccination, including one in the 25-μg group who had urticaria on both legs, with onset… Read More »
“We have a statewide pandemic. It’s no longer one or two regions,” Edwards told reporters in Baton Rouge. Edwards’ announcement comes as the United States passed 3 million coronavirus cases. Louisiana’s health department reported 1,891 new cases Wednesday, 95% of which are from community spread, according to Edwards. Data from Johns Hopkins University shows the… Read More »
NEW YORK/LONDON (Reuters) – An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to controversy around a drug championed by U.S. President Donald Trump. Three of the authors of the article retracted it, citing concerns about the quality and veracity of data in… Read More »